Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Pressure Control to Reduce Renal Risk for Type 2 Diabetes Mellitus

NCT03477786 is registered in ClinicalTrials.gov with National Health Research Institutes, Taiwan as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03477786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Pressure Control to Reduce Renal Risk for Type 2 Diabetes Mellitus
Lead sponsor
National Health Research Institutes, Taiwan
Phase
Not applicable
Overall status
Unknown status
Start date
October 28, 2013
Completion date
December 31, 2023
Enrollment
1,500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, type 2 diabetes mellitus